Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 CNY | +2.06% |
|
+5.04% | -7.09% |
Jan. 29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
Oct. 25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration